[go: up one dir, main page]

FI962813A7 - Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells - Google Patents

Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells Download PDF

Info

Publication number
FI962813A7
FI962813A7 FI962813A FI962813A FI962813A7 FI 962813 A7 FI962813 A7 FI 962813A7 FI 962813 A FI962813 A FI 962813A FI 962813 A FI962813 A FI 962813A FI 962813 A7 FI962813 A7 FI 962813A7
Authority
FI
Finland
Prior art keywords
peripheral blood
mononuclear cells
blood mononuclear
cytolytic activity
stimulate cytolytic
Prior art date
Application number
FI962813A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI962813A0 (en
FI962813L (en
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962813A7 publication Critical patent/FI962813A7/en
Publication of FI962813A0 publication Critical patent/FI962813A0/en
Publication of FI962813L publication Critical patent/FI962813L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI962813A 1994-01-20 1994-01-20 Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells FI962813L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (en) 1994-01-20 1994-01-20 Cytolytic activity of peripheral blood mononuclear cells activated by interleukin-10
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (3)

Publication Number Publication Date
FI962813A7 true FI962813A7 (en) 1996-07-11
FI962813A0 FI962813A0 (en) 1996-07-11
FI962813L FI962813L (en) 1996-07-11

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962813A FI962813L (en) 1994-01-20 1994-01-20 Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells

Country Status (10)

Country Link
EP (1) EP0740552A1 (en)
JP (1) JPH09508116A (en)
CN (1) CN1142186A (en)
AU (1) AU707019B2 (en)
FI (1) FI962813L (en)
NO (1) NO963029L (en)
NZ (1) NZ259584A (en)
PL (1) PL175343B1 (en)
SK (1) SK91696A3 (en)
WO (1) WO1995019780A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685931B1 (en) 1998-12-22 2004-02-03 Schering Corporation Treatment of hepatitis C virus infections with interleukin-10
EP1324779B1 (en) 2000-09-29 2011-07-20 Schering Corporation Pegylated interleukin-10
RU2322452C2 (en) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Immunomodulating composition
CA2664304C (en) 2006-09-28 2017-08-22 Schering Corporation Use of pegylated il-10 to treat cancer
WO2009003185A1 (en) * 2007-06-27 2008-12-31 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
WO2010077853A2 (en) 2008-12-17 2010-07-08 Schering Corporation Mono- and di-peg il-10 production; and uses
US9943568B2 (en) 2013-04-18 2018-04-17 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating cancer
EP3434277A1 (en) 2013-06-17 2019-01-30 Armo Biosciences, Inc. Method for assessing protein identity and stability
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN120242030A (en) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 Methods of using interleukin-10 to treat diseases and conditions
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP2017536098A (en) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド Interleukin-15 composition and use thereof
ES2941234T3 (en) 2014-10-22 2023-05-19 Armo Biosciences Inc Methods of using interleukin-10 for the treatment of diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN107847583A (en) 2015-05-28 2018-03-27 阿尔莫生物科技股份有限公司 PEGylated Interleukin 10 for treating cancer
EP3341012B1 (en) 2015-08-25 2025-07-30 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2023072859A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074879T3 (en) * 1991-01-16 1995-09-16 Schering Corp USE OF INTERLEUKIN-10 IN ADOPTIVE CANCER IMMUNOTHERAPY.
JP3260368B2 (en) * 1991-01-16 2002-02-25 シェリング・コーポレーション Treatment of neoplastic disease with interleukin-10
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
JPH09508116A (en) 1997-08-19
CN1142186A (en) 1997-02-05
SK91696A3 (en) 1997-04-09
NO963029L (en) 1996-09-19
NZ259584A (en) 1998-01-26
AU5842594A (en) 1995-08-08
WO1995019780A1 (en) 1995-07-27
FI962813A0 (en) 1996-07-11
EP0740552A1 (en) 1996-11-06
PL175343B1 (en) 1998-12-31
PL315513A1 (en) 1996-11-12
NO963029D0 (en) 1996-07-19
AU707019B2 (en) 1999-07-01
FI962813L (en) 1996-07-11

Similar Documents

Publication Publication Date Title
FI962813A7 (en) Use of IL-10 to stimulate cytolytic activity of peripheral blood mononuclear cells
FR2612939B1 (en) SKIN EQUIVALENT
BR8705461A (en) INTEGRAL DISPOSABLE ABSORBENT ITEM
PT86906A (en) DEPILATOR TO REMOVE BODY HAIR
ATA47787A (en) SOLID ORAL CARE AGAINST TOOTHSTONE AND BODY ODOR
IT1213915B (en) ANTI-SOLAR COSMETIC PREPARATION FOR FACE AND BODY
DE3750934D1 (en) Treatment of non-acne inflammatory and infectious skin diseases.
NO178094C (en) skin Care Preparations
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
DK295190D0 (en) COSMETICS AND SKIN TREATMENT COMPOSITIONS
KR880005157A (en) Acrylic copolymer and skin protection agent
IT1074824B (en) METAL-CARBONY CLUSTERS PREPARATION METHOD IMMOBILIZED IN ZEOLITES AND THEIR USE AS HETEROGENEOUS CATALYSTS
PL316433A1 (en) Analogues of human alpha-1-antichimotropsin exhibiting inhibitory activity in respect to elastase
DK489587A (en) MEDICAL SKIN PREPARATION
ZA94212B (en) Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
KR890701004A (en) Preparation of plant with improved physiological effect and use of the plant
DE3650451D1 (en) Mental illness therapeutic agent
FI883723A7 (en) Human monoclonal antibodies and therapeutic agents containing them as active ingredients against infectious diseases
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
IT1196887B (en) COLLECTION POCKET TO CARRY OUT QUICK MEDICAL ANALYSIS
FI891118A7 (en) Skin cleanser, conditioner and massage medicine applicator
ZA862321B (en) Use of efomycins as performance promoters in animals,efomycins and their preparation
GB2172704B (en) Antigenically active protein and its use in the diagnosis of gonorrhoea
FR2594690B1 (en) REGENERATING AND STIMULATING COMPOSITIONS OF THE DERMIS
GB9701919D0 (en) Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1